I posted this originally under a different message, but the way things thread it was lost in the clutter.
I've been using the NxStage System 1 and Pureflow at home since December 2009. I first used it in the short daily modality and I am now using it for slow, extended, daily dialysis. I actually only treat 5 days a week. Previously I have done peritoneal dialysis, in-center hemodialysis, and had a kidney transplant.
I'm very happy with the NxStage system. It is the only home hemodialysis system that provides the patient with the flexibility to travel with their system and continue the frequent modality. Other home users (with Fresineus, for example) still generally only dialyze three days a week. They also must find a clinic and get scheduled if planning to travel. Those systems also require separate power, a separate water filtration system, and are more complex to set up, maintain, use, and clean.
The ONLY complaint I have about the NxStage system is that the dialysis machine, while portable, is too heavy for one person to carry. It is easy to set up, easy to use, and can be used anywhere there is normal electric power and a drain. For travel, the clinic prescribes and NxStage provides hanging bags of pre-mixed dialysis solution, so you don't even really have to have a source of water.
I have felt substantially better since I started the extended treatments. My lab values have improved, and the measured clearances are good. I'm fairly certain that I should be able to continue dialysis with NxStage indefinitely.
From my perspective as a patient, the product is a winner. As an investor, I would wonder why the company isn't doing more to get into every clinic and provide promotional material to encourage patients to consider the NxStage system.
Occasionally we hear from a user, perhaps one of those was you under a different ID, gotta love Yahoo!
What IS frustrating about this company is they have had the PRODUCT for many years - I'd argue first mover for a decent home solution.
But I don't recall if different management came in after R&D and FDA approval or if the old folks lack the skill set to grow this company.
They worry about themselves and not patients or investors IMO. From buying companies to keeping cash low to golden parachutes rather than truely expanding the at home business.
They have done moves like giving controlling share away effectively to "buy" a company when the renal centers were screaming for trainers and NXTM cut back on trainers. Basically literally virtually gave away rights to their machine in other parts of the world. What funds were raised didn't help th ebusiness, but if I recall their salaries and bonuses did go up!
May be the biggest missed opportunity in the 30 years I've been investing. Seriousely.
I don't follow so closely anymore because all that does is remind me of how mgmt has dropped the ball for patients and stock holders while rewarding themselves handsomely. And always making the company in the worst financial position and padding they golden parachutes so a takeover is less likely.
Must be no real independent folks on the board. When I get time I guess I'll look into that.